Daily Intelligence Brief
Daily Docket: Talc and Hair Relaxer Lead 79 New Filings
LexGenius tracked 79 new filings yesterday, with the Johnson & Johnson Talcum Powder Products Liability Litigation and the Hair Relaxer Products Liability Litigation combining for 35 suits to dominate the daily docket. Reichert Armstrong Law Office filed a new claim in the Grand Forks Public School District Sex Abuse Litigation (D.N.D., 3:26-cv-00111), marking an emerging institutional accountability action in a jurisdiction not previously tracked on sex abuse dockets. Trammell PC led talc volume with 9 filings, supported by Wagstaff Law Firm (6) and Napoli Shkolnik (2). In hair relaxer, Morgan & Morgan PA drove 6 suits with Dicello Levitt LLP adding 4. Liakos Law APC filed Spradley v. Nevro Corporation (3:26-cv-03180, N.D. Cal.) — the second Nevro Spinal Cord Stimulator complaint in three days, signaling early plaintiff-side traction for an emerging device tort.Salesforce Enters Hotel Trafficking Liability Fracture With Dual California Filings
Two new federal sex trafficking complaints against Salesforce, Inc. filed by Potter Handy LLP in the Central District of California — Salesforce, Inc. Sex Trafficking Litigation (2:26-cv-03972) and Salesforce Sex Trafficking Litigation (2:26-cv-03771) — expand corporate liability theories beyond hospitality defendants into enterprise software platforms. The filings name Salesforce alongside hotel operators, alleging the company's customer relationship management tools facilitated trafficking operations by enabling defendants to track and manage victim interactions. This marks a notable expansion of TVPRA theories following the JPML's prior denial of MDL consolidation for hotel sex trafficking claims, leaving practitioners to pursue fragmented litigation across multiple districts. The Salesforce actions suggest plaintiff firms are testing whether software vendors with knowledge of client business models face derivative liability under trafficking statutes — a theory that, if sustained, could draw additional technology defendants into the litigation pool.Allergan Breast Implant MDL Adds New Filing as June Bellwether Looms
Levin Papantonio filed a new complaint in the Allergan Biocell Textured Breast Implant Products Liability Litigation (MDL 2921) (D.N.J., 2:26-cv-03952), adding to a docket of over 1,480 pending cases alleging the textured implants cause BIA-ALCL, a rare form of non-Hodgkin lymphoma. The filing comes as the litigation approaches a critical inflection point — the first bellwether trial is scheduled for June 15, 2026, with a second set for October 2026, both designed to establish damages benchmarks and test causation theories before Judge Brian R. Martinotti. For practitioners, the upcoming bellwether sequence will set the valuation framework for potential global settlement discussions, making pre-trial discovery rulings and expert retention in the coming weeks decisive.Generated by LexGenius Feed. Signals sourced from PACER federal court dockets, FDA/OpenFDA adverse event database, Federal Register, PubMed, and Google News.
